No Detail Found!

Chitinase-3-like protein 1: reference interval of a healthy population and its diagnostic value for liver fibrosis in Pakistan

Author(s)
Faryal Husnain Department of Chemical Pathology and Immunology, Chughtai Institute of Pathology, Lahore, Pakistan.
Muhammad Dilawar Khan Department of Chemical Pathology and Immunology, Chughtai Institute of Pathology, Lahore, Pakistan.
Omar Rasheed Chughtai Department of Chemical Pathology and Immunology, Chughtai Institute of Pathology, Lahore, Pakistan.
Akhtar Rasheed Chughtai Department of Chemical Pathology and Immunology, Chughtai Institute of Pathology, Lahore, Pakistan.
Shakeel Ashraf Department of Chemical Pathology and Immunology, Chughtai Institute of Pathology, Lahore, Pakistan.
Muhammad Usman Department of Chemical Pathology and Immunology, Chughtai Institute of Pathology, Lahore, Pakistan.
Abstract
Chitinase-3-like protein 1 (CHI3L1) is an upcoming biomarker for the diagnosis of liver fibrosis. The reference intervals (RIs) for CHI3L1 have not been established in the Pakistani population. Thus, this study aimed to determine the RIs in our population and the cut-of value for diagnosis of hepatic fibrosis. Methods: This is a cross-sectional study. A total of 408 participants (202 healthy and 206 diagnosed liver fibrosis cases) were recruited. Serum CHI3L1 level was measured on CHI3L1 kits (Proprium Biotech Co. Ltd) by manual enzyme-linked immunosorbent assay. The RIs were estimated by percentile and working normal method. Results: The distribution of CHI3L1 values showed no remarkable variation with gender and age. The 95% RI of CHI3L1 was 12.80-81.80 ng/ ml in healthy Pakistani subjects and the cut-of for the diagnosis was 102.12 ng/ml in hepatic fibrosis cases. Conclusion: The RIs in healthy adults and the cut-of for the diagnosis of hepatic fibrosis of serum CHI3L1 were determined in a selective adult Pakistani population. This will be a useful reference for further local and international studies.
Publication Details
Page(s) 164-169
Published Journal: Biomedica, Volume: 37, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
non-alcoholic faty liver disease (NAFLD), hepatic fibrosis, non-alcoholic steatohepatis (NASH), hepatocellular carcinoma, Chitinase-3-like protein 1, Reference interval, Cirrhosis
References
Pellicoro A,Ramachandran P,Iredale JP,Fallowfield JA .2014 .Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol, 14(3) : 181-94.
Huang H,Wu T,Mao J,Fang Y,Zhang J,Wu L .2015 .CHI3L1 is a liver-enriched, noninvasive biomarker that can be used to stage and diagnose substantial hepatic fibrosis. OMICS, 19(6) : 339-45.
Kjaergaard AD,Johansen JS,Bojesen SE,Nordestgaard BG .2016 .Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. Crit Rev Clin Lab Sci, 53(6) : 396-408.
Nøjgaard C,Johansen JS,Christensen E,Skovgaard LT,Price PA,Becker PU .2003 .Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J Hepatol, 8278(03) : 00184-3.
Sturgeon CM,Sprague S,Almond A,Cavalier E,Fraser WD,Algeciras-Schimnich A .2016 .Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - a view from the IFCC working group for PTH. Clin Chim Acta, 10 : 42.
Ichihara K,Ozarda Y,Barth JH,Klee G,Qiu L,Erasmus R .2016 .A global multicenter study on reference values: 1. Assessment of methods for derivation and comparison of reference intervals. Clin Chim Acta, 09(1) : 70-82.
Jones GR,Koetsier S. .2017 .Uptake of recommended common reference intervals for chemical pathology in Australia. , 54(3) : 395-7.
Horn PS,Pesce AJ .2003 .Reference intervals: an update. Clin Chim Acta, 8981(03) : 00133-5.
Boyd .2010 .cited 2021 Mar]. , : .
Wang L,Liu T,Zhou J,You H,Jia J .2018 .Changes in serum chitinase 3-like 1 levels correlate with changes in liver fibrosis measured by two established quantitative methods in chronic hepatitis B patients following antiviral therapy. Hepatol Res, 48(3) : E283-90.
Horn PS,Pesce AJ .2003 .Reference intervals: an update. Clin Chim Acta, 8981(03) : 00133-5.
Libreros S,Garcia-Areas R,Iragavarapu-Charyulu V .2013 .CHI3L1 plays a role in cancer through enhanced production of proinflammatory/pro-tumorigenic and angiogenic factors. Immunol Res, 57(1-3) : 99-105.
Zhao T,Su Z,Li Y,Zhang X,You Q .2020 .Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther, 5(1) : 201-21.
Kang Q,Chen J,Luo H,Tan N,Gao H,Zhang X .2020 .Decrease in chitinase 3-like protein 1 levels reflects improvement in liver fibrosis after HCV eradication. Dis Markers, : 9.
Berres ML,Papen S,Pauels K,Schmitz P,Zaldivar MM,Hellerbrand C .2008 .A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. J Hepatol, 09(2) : 370-6.
Yan C,Hu J,Yang J,Chen Z,Li H,Wei L .2018 .Serum ARCHITECT PIVKA-II reference interval in healthy Chinese adults: sub-analysis from a prospective multicenter study. Clin Biochem, 02 : 32-6.
Katayev A,Balciza C,Seccombe DW .2010 .Establishing reference intervals for clinical laboratory test results: is there a better way?. Am J Clin Pathol, 133(2) : 180-6.
Saleh AA,Alhanafy AM,Elbahr O,El-Hefnawy SM .2020 .Chitinase 3-like 1 gene (T/C) polymorphism and serum YKL-40 levels in patients with hepatocellular carcinoma. Meta Gene, 24(1) : 100686.
Mushtaq S,Ghani E,Azam K,Hussain T,Kumagai E,Mano Y,Yoshio S,Shoji H,Sugiyama M,Korenaga M .2016 .Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep, 6(3) : 35282-92.
0

Citations

0

Downloads

17

Views